Pharmacological anti-remodelling effects of disease-modifying drugs in heart failure with reduced ejection fraction

M Correale, P Mazzeo, L Tricarico, F Croella… - Clinical Drug …, 2022 - Springer
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …
被引用次数：8 相关文章

Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

M Correale, P Mazzeo, L Tricarico… - Clinical drug …, 2022 - pubmed.ncbi.nlm.nih.gov
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …
[PDF] researchgate.net

[PDF][PDF] Pharmacological Anti‑Remodelling Effects of Disease‑Modifying Drugs in Heart Failure with Reduced Ejection Fraction

M Correale, P Mazzeo, L Tricarico… - Clinical Drug …, 2022 - researchgate.net
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …

Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction.

M Correale, P Mazzeo, L Tricarico, F Croella… - Clinical Drug …, 2022 - europepmc.org
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …

Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

M Correale, P Mazzeo, L Tricarico… - Clinical Drug …, 2022 - search.proquest.com
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …

Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction

M Correale, P Mazzeo, L Tricarico, F Croella… - CLINICAL DRUG …, 2022 - fair.unifg.it
Cardiac remodelling is an adverse phenomenon linked to heart failure progression and an
important contributor to heart failure severity. Cardiac remodelling could represent the real …